How do ACE inhibitors, ARBs or ARNI medicines help my heart? 

When you have heart failure, your body tries to compensate for the weak pump by releasing hormones that tighten your blood vessels and hold onto salt and water. While this helps in the short term, it eventually creates a ‘noble’ burden that the heart cannot handle. ACE inhibitors, ARBs, and the newer ARNI medicines are designed to block these harmful hormonal pathways. They do not just make you feel better; they physically change the way your heart works, preventing it from stretching further and helping it to pump more efficiently. 

What We’ll Discuss in This Article 

• The role of the Renin-Angiotensin System in heart failure 

• How ACE inhibitors relax blood vessels and lower pressure 

• Why ARBs are often the first alternative to ACE inhibitors 

• The ‘double action’ of ARNI (Sacubitril/valsartan) 

• Why these drugs are essential for heart ‘remodelling’ 

• The critical 36-hour gap when switching medicines 

• Monitoring kidney function and potassium levels 

ACE Inhibitors: The First Line of Defence 

Angiotensin-Converting Enzyme (ACE) inhibitors, such as Ramipril, Lisinopril, or Enalapril, have been the cornerstone of heart failure treatment for decades. 

How they work: 

They stop the body from producing a hormone called Angiotensin II. This hormone is a powerful ‘vessel-tightener’ that forces the heart to push against high pressure. 

• Vessel Dilation: By reducing this hormone, ACE inhibitors allow blood vessels to relax and widen. 

• Lowering Afterload: This reduces the resistance the heart faces, making it much easier to eject blood. 

• Preventing Remodelling: They help stop the heart muscle from becoming thin and scarred (remodelling). 

The Side Effect Note: 

The most common issue with ACE inhibitors is a persistent dry, tickly cough. This happens because the medicine also affects a substance called bradykinin in the lungs. 

ARBs: The Reliable Alternative 

Angiotensin-II Receptor Blockers (ARBs), such as Candesartan or Losartan, work in a very similar way to ACE inhibitors but at a different point in the chemical chain. 

How they work: 

Instead of stopping the production of the hormone, they block the ‘receptors’ (the buttons) that the hormone needs to press to cause damage. 

• No Cough: Because they do not affect bradykinin, they almost never cause the dry cough associated with ACE inhibitors. 

• Equal Protection: They provide essentially the same protection for the heart and kidneys as ACE inhibitors. 

According to the NHS, ARBs are usually prescribed if a patient cannot tolerate the cough or other side effects of an ACE inhibitor. 

ARNI: The ‘Double Action’ Breakthrough 

An Angiotensin Receptor-Neprilysin Inhibitor (ARNI), specifically Sacubitril/valsartan (often known by the brand name Entresto), is a newer and more powerful medication.¹¹ 

How it works: 

This is a single tablet that does two jobs at once: 

1. The ARB Part: It blocks the harmful effects of Angiotensin II (the valsartan component). 

2. The Neprilysin Part: It stops the breakdown of beneficial proteins called natriuretic peptides (the sacubitril component). These peptides are the heart’s natural way of getting rid of salt, water, and relaxing vessels. 

The Benefit: 

Research shows that ARNI is even more effective than standard ACE inhibitors at reducing hospital admissions and helping people live longer with heart failure. It is often prescribed as a ‘noble’ upgrade for patients who still have symptoms despite being on standard tablets. 

Comparing the Three Medicines 

Medicine Type	Examples	Main Action	Key Benefit
ACE Inhibitor	Ramipril, Lisinopril	Stops production of Angiotensin II	Proven long-term protection; inexpensive.
ARB	Candesartan, Losartan	Blocks Angiotensin II receptors	Same benefits as ACEi but without the cough.
ARNI	Sacubitril/valsartan	Blocks harmful hormones AND keeps good ones	Stronger symptom relief and survival benefit.

The Critical 36-Hour Gap 

If your doctor decides to switch you from an ACE inhibitor to an ARNI, there is one ‘noble’ safety rule you must follow: the washout period. 

• The Rule: You must stop your ACE inhibitor for at least 36 hours before taking your first dose of ARNI. 

• The Reason: Taking them too close together significantly increases the risk of a rare but serious swelling of the face, lips, and airway (angioedema). 

Monitoring and Safety 

All three of these medications affect how your kidneys filter blood and how much potassium your body keeps. 

What to expect: 

• Frequent Blood Tests: You will need blood tests every 1 to 2 weeks when you start or change a dose. This is to ensure your kidneys are coping and your potassium hasn’t risen too high. 

• Low Blood Pressure: Because these drugs widen your vessels, you may feel lightheaded when standing up quickly. This often settles as your body adjusts to the ‘noble’ new pressure level. 

Conclusion 

ACE inhibitors, ARBs, and ARNI are the foundation of heart failure recovery. By relaxing the blood vessels and blocking harmful hormones, they reduce the mechanical strain on the heart muscle. While ACE inhibitors and ARBs provide excellent protection, the newer ARNI combination offers a more comprehensive ‘double action’ approach. Regardless of which one you are prescribed, the goal remains the same: to protect your heart from further damage and give the muscle the best possible environment to regain its strength. 

Emergency Guidance 

If you experience any sudden swelling of your lips, tongue, or throat, or if you have severe difficulty breathing, call 999 immediately. This is an emergency, especially if you have recently started one of these medications. 

FAQ Section 

Authority Snapshot 

This article was written by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in cardiology, internal medicine, and emergency care. Dr. Fernandez has managed critically ill patients and provided comprehensive inpatient care within the NHS framework. This guide draws upon established pharmacological principles and clinical guidelines from NICE and the British Heart Foundation to explain how these key medications protect and support a failing heart.